DK0575522T3 - Polypeptider afledt fra det humane immundeficiensvirus endonukleaseprotein - Google Patents

Polypeptider afledt fra det humane immundeficiensvirus endonukleaseprotein

Info

Publication number
DK0575522T3
DK0575522T3 DK92908719T DK92908719T DK0575522T3 DK 0575522 T3 DK0575522 T3 DK 0575522T3 DK 92908719 T DK92908719 T DK 92908719T DK 92908719 T DK92908719 T DK 92908719T DK 0575522 T3 DK0575522 T3 DK 0575522T3
Authority
DK
Denmark
Prior art keywords
leu
immunodeficiency virus
human immunodeficiency
polypeptides derived
polypeptide
Prior art date
Application number
DK92908719T
Other languages
Danish (da)
English (en)
Inventor
Francesca Chiodi
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Application granted granted Critical
Publication of DK0575522T3 publication Critical patent/DK0575522T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/974Aids related test
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92908719T 1991-03-15 1992-03-03 Polypeptider afledt fra det humane immundeficiensvirus endonukleaseprotein DK0575522T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/670,296 US5229364A (en) 1991-03-15 1991-03-15 Polypeptides derived from the human immunodeficiency virus endonuclease protein
PCT/US1992/001813 WO1992016219A1 (fr) 1991-03-15 1992-03-03 Polypeptides derives de la proteine endonuclease du virus de l'immunodeficience humaine

Publications (1)

Publication Number Publication Date
DK0575522T3 true DK0575522T3 (da) 1998-10-07

Family

ID=24689836

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92908719T DK0575522T3 (da) 1991-03-15 1992-03-03 Polypeptider afledt fra det humane immundeficiensvirus endonukleaseprotein

Country Status (13)

Country Link
US (2) US5229364A (fr)
EP (1) EP0575522B1 (fr)
JP (1) JPH07119235B2 (fr)
AT (1) ATE166068T1 (fr)
AU (1) AU683812B2 (fr)
CA (1) CA2105664C (fr)
DE (1) DE69225473T2 (fr)
DK (1) DK0575522T3 (fr)
ES (1) ES2118131T3 (fr)
FI (1) FI111731B (fr)
IE (1) IE920832A1 (fr)
NO (1) NO308855B1 (fr)
WO (1) WO1992016219A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229364A (en) * 1991-03-15 1993-07-20 Francesca Chiodi Polypeptides derived from the human immunodeficiency virus endonuclease protein
ES2267094T3 (es) * 1991-12-23 2007-03-01 Novartis Vaccines And Diagnostics, Inc. Conjunto de sondas de vih para su uso en ensayos de hibridacion en sandwich en fase de disolucion.
US5590213A (en) * 1995-02-15 1996-12-31 David Clark Company Inc. Headset with adjustable headpad
DE19717187A1 (de) * 1997-04-24 1998-10-29 Pagendarm Technologie Gmbh Vorrichtung zur Behandlung, insbesondere Trocknung von Materialbahnen
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
US20050031639A1 (en) 2003-05-12 2005-02-10 Yamamoto Janet K. Materials and methods for immunizing against FIV infection
WO2010056441A1 (fr) * 2008-11-17 2010-05-20 Dow Global Technologies Inc. Procédés de réduction du formaldéhyde transporté par l’atmosphère

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620330B2 (en) * 1987-05-29 1992-02-20 Smithkline Beckman Corporation Immunodiagnostic assays using chimeric antigens
FR2640877A1 (fr) * 1988-12-06 1990-06-29 Centre Nat Rech Scient
AU5184190A (en) * 1989-02-23 1990-09-26 University Of Ottawa Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine
US5229364A (en) * 1991-03-15 1993-07-20 Francesca Chiodi Polypeptides derived from the human immunodeficiency virus endonuclease protein

Also Published As

Publication number Publication date
DE69225473T2 (de) 1998-10-01
AU7546896A (en) 1997-02-20
JPH07119235B2 (ja) 1995-12-20
AU683812B2 (en) 1997-11-20
US5401628A (en) 1995-03-28
AU1572592A (en) 1992-10-21
EP0575522A1 (fr) 1993-12-29
AU671950B2 (en) 1996-09-19
WO1992016219A1 (fr) 1992-10-01
JPH06505275A (ja) 1994-06-16
FI934022A (fi) 1993-09-14
DE69225473D1 (de) 1998-06-18
FI111731B (fi) 2003-09-15
FI934022A0 (fi) 1993-09-14
NO933269D0 (no) 1993-09-14
IE920832A1 (en) 1992-09-23
ATE166068T1 (de) 1998-05-15
ES2118131T3 (es) 1998-09-16
CA2105664C (fr) 1998-08-25
EP0575522B1 (fr) 1998-05-13
CA2105664A1 (fr) 1992-09-16
EP0575522A4 (fr) 1994-11-23
US5229364A (en) 1993-07-20
NO308855B1 (no) 2000-11-06
NO933269L (no) 1993-11-12

Similar Documents

Publication Publication Date Title
ATE236981T1 (de) Von menschlichen t-zellen immunodominante epiropen des virus der c-hepatitis
ATE81779T1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
ES2101388T3 (es) Antigenos sinteticos para la deteccion de anticuerpos para el virus de la hepatitis c.
KR910700062A (ko) 마가이닌 펩타이드의 결실 동족체
DE3687761D1 (de) Herstellung des menschlichen von-willebrand-faktors durch rekombinante dns.
DK0575522T3 (da) Polypeptider afledt fra det humane immundeficiensvirus endonukleaseprotein
DE69131662D1 (de) Lipopeptide, T-cytotoxische Lymphocyte aktivierend, und deren Verwendung als Vakzine
KR870000356A (ko) 메티오닐 단백질로부터 n-말단 메티오닌을 제거하는 방법
EP1878797A3 (fr) Peptides antigéniques pour le groupage du virus de l'hépatite C, kit comprenant ceux-ci et procédé de groupage les utilisant
IL102615A (en) Immunoassy kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-ii and methods for te detections of antibodies
DK0732339T3 (da) Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf
DE69018325D1 (de) Antigen-Protein der Sporozoit- und hepatischen Phase von P. falciparum.
DK0426314T3 (da) HIV-relaterede peptider
PT87239A (pt) Process for the preparation of peptides
WO1994004565A3 (fr) Vaccin vnpi
KR900701834A (ko) 사람 호중구 화학주성 인자를 사람에게 투여하는 것에 의한 면역결핍 상태에 의해 유발된 질병의 치료방법
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same
SE8701294D0 (sv) Hiv-peptid
ES2009280A6 (es) Un metodo para detectar anticuerpos al virus hiv-1 en una muestra.